Roche Holding AG Akt-0.20% CHF230.28B ...

After hours: January 31 at 5:34:16 PM EST Loading Chart for AKRO ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on January 27 and set a price target of $73.00. The company’s shares closed yesterday at ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

I’ve asked several residents if they had any financial classes during high school. It seems there was none. This seems to be quite important when they start a lifetime of working. Perhaps some ...